Want to join the conversation?
$COST's 2Q16 net sales rose 3% to $27.6Bil. Total company comp sales were 1%, with comp sales of 3% for the US region, negative 7% for Canada and negative 3% for Other International. Feb. comp sales for total company were zero; and excluding negative impacts from gas price deflation and FX, Feb. comp sales were 4%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?